Clinical Trial Update: A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update describing a transiliac crest bone histology and histomorphometry study in postmenopausal women with low bone mass or osteoporosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Amgen | Conditions: Low Bone Mass, Low Bone Mineral Density | Phase 2 | Status: COMPLETED | Results posted: 2013-10-17